INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined onions. Clear

People assigned to a diet, food or program and measured.

2 studies

2017 / Randomized controlled trial

Fresh yellow onion intake lowered fasting glucose and insulin resistance during breast cancer chemotherapy.

Eligible breast cancer patients receiving doxorubicin-based chemotherapy were randomized to an 8-week intervention with high daily onion intake (100 to 160 g/d) or low daily onion intake (30 to 40 g/d). Analyses of 23 participants per group revealed that high onion intake significantly decreased fasting blood glucose and insulin levels relative to low onion intake (P < .001). Post-treatment insulin resistance assessed by HOMA-IR was also significantly lower in the high onion group (P < .05).

Jafarpour-Sadegh F, Montazeri V, Adili A, et al. Integr Cancer Ther, 2017. PMID 27352956

2015 / Randomized controlled trial

High onion intake lowered cancer markers during doxorubicin chemotherapy

A double-blind trial randomized 56 breast cancer patients receiving doxorubicin into groups consuming 100-160 g/day or 30-40 g/day of fresh yellow onion for eight weeks. Participants consuming the higher amount of onion showed significant reductions in carcinoembryonic antigen, cancer antigen-125, and alkaline phosphatase levels compared to the low-onion group (P < 0.05).

Jafarpour-Sadegh F, Montazeri V, Adili A, et al. Asian Pac J Cancer Prev, 2015. PMID 26625755